Free Trial

Fresh Tracks Therapeutics Q2 2023 Earnings Report

Fresh Tracks Therapeutics logo
$0.74 0.00 (-0.34%)
(As of 12/20/2024 05:18 PM ET)

Fresh Tracks Therapeutics EPS Results

Actual EPS
-$0.39
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Fresh Tracks Therapeutics Revenue Results

Actual Revenue
$0.05 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fresh Tracks Therapeutics Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

Fresh Tracks Therapeutics Earnings Headlines

⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
Fresh Tracks Therapeutics Inc (FRTX)
See More Fresh Tracks Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fresh Tracks Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresh Tracks Therapeutics and other key companies, straight to your email.

About Fresh Tracks Therapeutics

Fresh Tracks Therapeutics (NASDAQ:FRTX) does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

View Fresh Tracks Therapeutics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings